Mean Liver Dose Evaluation by Lyman NTCP Modeling With Stereotactic Body Radiation therapy to Minimize Radiation-Induced Liver Disease for Inoperable Hepatocellular Carcinoma

Mean Liver Dose Evaluation by Lyman NTCP Modeling With Stereotactic Body Radiation therapy to Minimize RadiationInduced Liver Disease for Inoperable Hepatocellular Carcinoma M. Camborde, E. Vollans, C. Crumley, R. Ma, R. Kosztyla, V. Moiseenko, C. Duzenli, D. Schellenberg, M. Khan, and S. Loewen; Department of Medical Physics, BC Cancer Agency, Vancouver, BC, Canada, Division of Radiation Therapy, BC Cancer Agency, Vancouver, BC, Canada, Division of Radiation Oncology, BC Cancer Agency, Vancouver, BC, Canada, Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, Division of Radiation Oncology, BC Cancer Agency Fraser Valley Centre, Surrey, BC, Canada, Department of Radiation Oncology, CancerCare Manitoba, Winnipeg, MB, Canada